Selected:
Ultra-efficient chip design enables extremely strong cryptography algorithms to run on energy-constrained edge devices.
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.